These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20730719)

  • 1. High concentrations of B-type natriuretic peptide and left ventricular diastolic dysfunction in patients with paroxysmal/persistent atrial fibrillation as possible markers of conversion into permanent form of arrhythmia: 1-year prospective evaluation.
    Dabrowski R; Borowiec A; Janas J; Firek B; Kowalik I; Smolis-Bak E; Luczak D; Sosnowski C; Kazimierska B; Szwed H
    Kardiol Pol; 2010 Aug; 68(8):893-900. PubMed ID: 20730719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptides in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G; Herman Z; Kosior D
    Cardiol J; 2008; 15(6):525-9. PubMed ID: 19039756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
    Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Goudis CA; Maliaraki NE; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE
    Am J Cardiol; 2010 Jan; 105(1):90-4. PubMed ID: 20102897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline B-type natriuretic peptide: a gender-specific predictor of procedure-outcome in atrial fibrillation patients undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Rong B; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    J Cardiovasc Electrophysiol; 2011 Aug; 22(8):858-65. PubMed ID: 21371160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
    Ata Y; Turk T; Ay D; Eris C; Demir M; Ari H; Ata F; Yavuz S; Ozyazicioglu A
    Heart Surg Forum; 2009 Aug; 12(4):E211-6. PubMed ID: 19683991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma brain natriuretic peptide levels after a successful maze procedure.
    Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M
    J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function.
    Moon J; Rim SJ; Cho IJ; Lee SH; Choi S; Chung WJ; Byun YS; Ryu SK; Pyun WB; Kim JY
    Clin Exp Hypertens; 2010; 32(8):540-6. PubMed ID: 21091364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
    Bakowski D; Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery.
    Wazni OM; Martin DO; Marrouche NF; Latif AA; Ziada K; Shaaraoui M; Almahameed S; Schweikert RA; Saliba WI; Gillinov AM; Tang WH; Mills RM; Francis GS; Young JB; Natale A
    Circulation; 2004 Jul; 110(2):124-7. PubMed ID: 15210589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation.
    Bakowski D; Wozakowska-Kaplon B; Opolski G
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):745-52. PubMed ID: 19545336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of oral amiodarone in patients with atrial fibrillation and congestive heart failure.
    Kawabata M; Hirao K; Hachiya H; Higuchi K; Tanaka Y; Yagishita A; Inaba O; Isobe M
    J Cardiol; 2011 Sep; 58(2):108-15. PubMed ID: 21831597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation.
    Shang YP; Lai L; Chen J; Zhang F; Wang X
    J Heart Valve Dis; 2005 Jul; 14(4):453-9. PubMed ID: 16116870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study.
    Knudsen CW; Omland T; Clopton P; Westheim A; Wu AH; Duc P; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
    J Am Coll Cardiol; 2005 Sep; 46(5):838-44. PubMed ID: 16139134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
    Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion.
    Tsuchida K; Tanabe K
    J Cardiol; 2004 Jul; 44(1):1-11. PubMed ID: 15334879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.